Acetaminophen does inhibit cyclooxygenase enzymes, but it does so weakly, inconsistently, and through an unusual chemical mechanism that sets it apart from traditional NSAIDs like ibuprofen or aspirin. The drug’s ability to reduce pain and fever cannot be fully explained by COX inhibition alone, and researchers now believe that much of its analgesic effect comes from entirely separate pathways in the brain, including the endocannabinoid system and serotonin-based pain circuits. After more than a century of use, acetaminophen remains one of the most common medications on the planet and one of the least understood.
How Acetaminophen Interacts with COX Enzymes
Acetaminophen does interact with COX-1 and COX-2, but not the way ibuprofen or naproxen do. Traditional NSAIDs physically block the active site of COX enzymes, preventing them from converting arachidonic acid into prostaglandins. Acetaminophen takes a different route: it acts as a reducing agent on the peroxidase portion of the COX enzyme, essentially switching the enzyme from its active, oxidized state back to an inactive, resting state.1Archives of Biochemistry and Biophysics. Mechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms This distinction matters because the reducing mechanism only works well when the surrounding concentration of peroxides is low.2PubMed. Paracetamol (Acetaminophen): mechanisms of action
In terms of selectivity, acetaminophen leans toward COX-2 over COX-1. One study in humans found roughly 4.4-fold greater inhibition of COX-2 compared to COX-1 in lab tests, and after people took the drug orally, COX-2 activity dropped by about 83% while COX-1 dropped by about 56%.3PubMed. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man That COX-2 reduction is comparable to what you see with dedicated COX-2 inhibitors. But the 4.4-fold selectivity is modest compared to purpose-built selective COX-2 drugs, which can reach selectivity ratios hundreds of times higher.4PubMed. Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition? Acetaminophen also never achieves the greater-than-95% COX-1 blockade needed to suppress platelet function, which is why it does not thin the blood the way aspirin does.3PubMed. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
Why It Fails as an Anti-Inflammatory
If acetaminophen inhibits COX-2 at levels comparable to NSAIDs, why doesn’t it reduce inflammation the way ibuprofen does? The answer lies in that peroxide-dependent mechanism. At sites of active inflammation, immune cells like neutrophils and macrophages churn out large quantities of peroxides. These high peroxide levels effectively overwhelm acetaminophen’s ability to keep COX in its resting state, rendering the drug nearly useless against prostaglandin production in inflamed tissue.2PubMed. Paracetamol (Acetaminophen): mechanisms of action In quieter environments where peroxide concentrations are low, such as the brain and the vascular endothelium, acetaminophen can effectively shut down prostaglandin synthesis. In a swollen, angry joint, it cannot.
This cellular selectivity has been measured directly. In endothelial cells stimulated with a low level of inflammatory signals, acetaminophen inhibited prostaglandin production at a very low concentration. But in platelets, which generate their own peroxides, the concentration needed was roughly 400 times higher.5PubMed Central. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases This enormous gap explains why acetaminophen relieves headaches and lowers fevers (both centrally mediated) but does little for the redness and swelling of a sprained ankle.
The COX-3 Idea That Didn’t Survive Translation
In 2002, researchers discovered a splice variant of COX-1 in dogs and named it COX-3. In insect cells engineered to produce canine COX-3, acetaminophen selectively inhibited the enzyme, and for a few years it seemed like the mystery was solved: maybe acetaminophen had its own special COX target all along. But the excitement was short-lived. In humans and rodents, the gene for COX-3 retains an extra segment of DNA that throws off the reading frame, producing a truncated, malformed protein with a completely different amino acid sequence than COX-1 or COX-2. This human version of “COX-3” lacks acetaminophen sensitivity entirely.6PubMed. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? The COX-3 hypothesis still appears in some older textbooks and occasional exam questions, but it does not explain how acetaminophen works in people.
The AM404 Metabolite and the Endocannabinoid System
The strongest competing explanation for acetaminophen’s painkilling ability has nothing to do with cyclooxygenase. Once acetaminophen crosses into the brain and spinal cord, an enzyme called FAAH converts it into a metabolite called AM404. This compound is chemically related to anandamide, one of the body’s own endocannabinoids, and it acts on several pain-related targets at once.7PubMed Central. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact
AM404 is a potent activator of TRPV1, a receptor on nerve cells involved in pain sensing. It also indirectly stimulates cannabinoid-1 (CB1) receptors by blocking the reuptake of anandamide, letting the body’s natural painkiller linger longer at the synapse. In the periaqueductal gray, a brain region that acts as a master switch for pain modulation, AM404 sets off a signaling cascade that runs through TRPV1, then through a series of intermediary signals, and ultimately lands on CB1 receptors.7PubMed Central. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact Some researchers now consider this AM404 pathway, not COX inhibition, to be the main analgesic mechanism of acetaminophen.8PubMed Central. Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action
Serotonin and the Brain’s Built-In Pain Brakes
The endocannabinoid story connects to yet another system: serotonin-based pathways that run from the brainstem down the spinal cord, dampening pain signals before they reach conscious awareness. Research in healthy volunteers showed that acetaminophen’s pain-relieving effect was completely blocked when participants received tropisetron, a drug that blocks a specific serotonin receptor subtype.9PubMed. Acetaminophen reinforces descending inhibitory pain pathways If acetaminophen worked purely through COX inhibition, a serotonin blocker should not have mattered at all.
Animal research has fleshed out how these two systems link together. The proposed sequence goes like this: FAAH converts acetaminophen to AM404, AM404 indirectly engages CB1 receptors, CB1 activation strengthens the descending serotonergic pathways from the brainstem, and serotonin then suppresses pain signaling in the spinal cord.10PubMed. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia The involvement of cannabinoid, serotonin, and potentially opioidergic, cholinergic, and other neurotransmitter systems makes acetaminophen’s mechanism look less like a single-target drug and more like a constellation of effects all happening in the central nervous system.11PubMed Central. The Contribution of Serotonergic Receptors and Nitric Oxide Systems in the Analgesic Effect of Acetaminophen: An Overview of the Last Decade
An Unresolved Debate
It would be convenient to say “acetaminophen’s pain relief comes from AM404 and serotonin, and the COX inhibition is irrelevant,” but that is probably too clean. The reality is that researchers still disagree. One line of evidence from transgenic mice suggests that acetaminophen works through inhibition of a COX-1 variant to produce its effects on body temperature, including both its fever-reducing action and its ability to cause mild hypothermia.12PubMed Central. Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action Meanwhile, in-vitro screens consistently show that acetaminophen is a weak COX inhibitor, and the drug’s in-vivo efficacy seems heavily dependent on local conditions like peroxide levels and arachidonic acid concentrations.4PubMed. Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
A separate line of research has even explored whether acetaminophen’s fever-lowering action partly involves direct inhibition of mitochondrial function. At pharmacologically relevant concentrations, acetaminophen reduced fatty acid oxidation in fat cells by about 30% and cut oxygen consumption by about a third. Its toxic metabolite NAPQI was even more potent, causing a roughly 63% drop in fatty acid oxidation.13PubMed Central. Inhibition of mitochondrial function: An alternative explanation for the antipyretic and hypothermic actions of acetaminophen Whether this mitochondrial effect plays a meaningful role in everyday use or is mainly relevant in overdose situations remains open.
The honest take is that acetaminophen likely works through multiple mechanisms simultaneously, and the relative contribution of each may vary depending on the type of pain, the tissue involved, and the dose. Categorizing it as simply “a COX inhibitor” undersells what is actually happening, but excluding COX from the picture entirely would also be wrong.
Why Acetaminophen and NSAIDs Work Better Together
If acetaminophen’s pain relief is mostly central and an NSAID’s pain relief is mostly peripheral, combining the two should attack pain from both directions. That is exactly what clinical studies show. In trials of dental pain, postoperative pain, and musculoskeletal conditions, pairing acetaminophen with an NSAID provides more pain relief than either drug alone, often enough to allow lower doses of both.14PubMed. A rationale for combining acetaminophen and NSAIDs for mild-to-moderate pain Experimental pain studies using isobolographic analysis, a mathematical method for testing whether two drugs merely add together or genuinely amplify each other, have confirmed that the combinations are synergistic rather than simply additive.15PubMed. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain
The basis for this synergy is precisely the different mechanistic profile of the two drug classes. Acetaminophen’s central actions, likely mediated by AM404 and serotonin, complement the peripheral COX-blocking action of NSAIDs in inflamed tissue.16Biomedicine & Pharmacotherapy. Pharmacological bases of combining nonsteroidal antiinflammatory drugs and paracetamol This is a practical payoff of the mechanistic debate: even if we don’t fully understand how acetaminophen works, the fact that it acts through different channels than NSAIDs makes the combination clinically useful.
Blood Pressure Effects You Might Not Expect
Because acetaminophen does inhibit COX-2 in some tissues, it may share one unwelcome property with other COX-2 inhibitors: an effect on blood pressure. A randomized, placebo-controlled crossover trial in people who already had high blood pressure found that taking acetaminophen regularly (1 gram, four times daily for two weeks) raised average daytime systolic blood pressure by about 4.7 mmHg compared to placebo, and diastolic blood pressure by about 1.6 mmHg.17PubMed Central. Regular acetaminophen use and blood pressure in people with hypertension: The PATH-BP Trial A systolic increase approaching 5 mmHg might not sound dramatic, but at a population level that magnitude of sustained blood pressure elevation is associated with a meaningful increase in cardiovascular risk.
This finding complicates the common clinical advice to reach for acetaminophen instead of NSAIDs when blood pressure is a concern. For occasional use, the effect is probably negligible. But for people taking acetaminophen daily for chronic pain, the blood pressure impact deserves attention, and the assumed safety advantage over NSAIDs may be smaller than previously thought.
Social Pain, Empathy, and Emotional Blunting
Some of the most surprising research on acetaminophen has come from outside traditional pharmacology altogether. Social psychologists noticed that the brain regions activated by social rejection overlap with those involved in physical pain. Experiments using brain imaging showed that acetaminophen reduced activity in the dorsal anterior cingulate cortex and anterior insula during social rejection, the same regions that light up during physical hurt.18PubMed. Acetaminophen reduces social pain: behavioral and neural evidence
The effect extends beyond the experience of one’s own distress. In one experiment, people who took acetaminophen reported less personal pleasure and less empathic feeling when reading about good things happening to others, though they could still accurately perceive that those experiences were positive.19PubMed Central. A Social Analgesic? Acetaminophen (Paracetamol) Reduces Positive Empathy EEG studies have corroborated these findings: people given acetaminophen showed altered brain wave patterns when viewing images of others in pain, suggesting the drug changes the neural response to empathy for pain.20PubMed. Acetaminophen changes Mu rhythm power related to pain empathy
These are laboratory effects under controlled conditions, and nobody is suggesting that taking a Tylenol for a headache will make you an emotionless shell. But the findings are a natural consequence of the drug’s broad central nervous system activity. If acetaminophen modulates endocannabinoid signaling, serotonin pathways, and emotional processing circuits in the brain, it should not be entirely surprising that its effects reach beyond physical pain sensation. The implications for people who take acetaminophen chronically are not yet clear, but the research reinforces that this drug is doing far more inside the brain than simply blocking an enzyme.
Prenatal Exposure and Ongoing Caution
Acetaminophen has long been considered the safest over-the-counter painkiller to take during pregnancy, and it remains the first-line recommendation for pain and fever in pregnant people. But a growing body of experimental and epidemiological research has raised questions about whether prenatal exposure might affect fetal development. A 2021 consensus statement signed by dozens of researchers and clinicians noted that accumulating evidence suggests prenatal acetaminophen exposure could increase the risks of certain neurodevelopmental, reproductive, and urogenital disorders in offspring.21Nature Reviews Endocrinology. Paracetamol use during pregnancy — a call for precautionary action
This does not mean pregnant people should avoid the drug when they genuinely need it for fever or significant pain, both of which carry their own risks to the fetus. The concern is more about casual, extended use. The mechanistic uncertainty surrounding acetaminophen adds an extra layer to the discussion: if the drug affects endocannabinoid signaling, serotonin systems, and possibly mitochondrial function, there are plausible biological pathways through which fetal exposure could matter during critical windows of development. Most major health organizations still recommend acetaminophen as the preferred analgesic in pregnancy but increasingly emphasize using the lowest effective dose for the shortest time needed.
The NAPQI Problem at High Doses
No discussion of acetaminophen’s mechanism is complete without mentioning what happens when the drug is taken in excess. The liver metabolizes most acetaminophen through safe pathways, but a small fraction gets converted by CYP enzymes, particularly CYP2E1, into a highly reactive metabolite called NAPQI. Under normal circumstances, the body’s glutathione supply quickly neutralizes NAPQI before it can do harm. In overdose, glutathione stores are exhausted, and NAPQI accumulates, binding to liver proteins and causing potentially fatal liver damage.22PubMed. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
This toxicity pathway is entirely separate from any COX-related mechanism and underscores how unusual acetaminophen is as a drug. At therapeutic doses it gently reduces a fever through brain-centered mechanisms. Push the dose just a few times higher and it becomes one of the most common causes of acute liver failure in the developed world. The narrow safety margin between therapeutic and toxic doses, combined with the drug’s presence in hundreds of combination products, makes accidental overdose a genuine public health concern, particularly because many people do not realize that their cold medicine, sleep aid, and pain reliever all contain the same active ingredient.